Related Experiment Video
Updated: Dec 15, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Children's rare disease cohorts: an integrative research and clinical genomics initiative
Shira Rockowitz1,2,3, Nicholas LeCompte1,2,3, Mary Carmack1,2,3
1Computational Health Informatics Program, Boston Children's Hospital, Boston, MA 02115 USA.
Insights
Creating a unified genomics learning system (GLS) harmonized pediatric rare disease data. This approach streamlines sequencing and integrates clinical data for improved research and diagnostics.
Area of Science:
- Genomics
- Bioinformatics
- Rare Diseases
Background:
- Genomic data is often fragmented across different research protocols and clinical settings.
- Harmonizing genomic data, especially for pediatric rare diseases, presents significant challenges for research institutions.
- Integrating diverse data types and stakeholder needs is crucial for effective genomics workflows.
Purpose of the Study:
- To present the outcomes of the Children's Rare Disease Cohorts (CRDC) initiative's first phase at Boston Children's Hospital.
- To establish a unified genomics learning system (GLS) for pediatric rare disease research and clinical practice.
- To create a broadly sharable, harmonized database of genomic and phenotypic data.
Main Methods:
- Developed a genomics learning system (GLS) integrating exome and genome sequencing data.
- Created a relational database for centralized storage and analysis of 8516 exomes and 112 genomes.
- Utilized manual annotation and natural language processing (NLP) for phenotype extraction from clinical records.
- Implemented machine learning algorithms for automated variant classification and prioritization.
Main Results:
- Successfully created a sharable database of 2441 exomes from 15 pediatric rare disease cohorts.
- The GLS integrates genomic, phenotypic, and clinical data, supporting 8516 exomes and 112 genomes.
- Automated variant classification and NLP-based phenotype extraction are integrated within the GLS.
- The platform demonstrates extensibility for future data and analytical system integration.
Conclusions:
- The Children's Rare Disease Cohorts initiative successfully established a harmonized genomics learning system.
- This unified approach facilitates centralized data storage, analysis, and sharing for pediatric rare diseases.
- The GLS provides a robust and extensible platform for advancing genomic research and clinical applications.
Abstract:
While genomic data is frequently collected under distinct research protocols and disparate clinical and research regimes, there is a benefit in streamlining sequencing strategies to create harmonized databases, particularly in the area of pediatric rare disease. Research hospitals seeking to implement unified genomics workflows for research and clinical practice face numerous challenges, as they need to address the unique requirements and goals of the distinct environments and many stakeholders, including clinicians, researchers and sequencing providers. Here, we present outcomes of the first phase of the Children's Rare Disease Cohorts initiative (CRDC) that was completed at Boston Children's Hospital (BCH). We have developed a broadly sharable database of 2441 exomes from 15 pediatric rare disease cohorts, with major contributions from early onset epilepsy and early onset inflammatory bowel disease. All sequencing data is integrated and combined with phenotypic and research data in a genomics learning system (GLS). Phenotypes were both manually annotated and pulled automatically from patient medical records. Deployment of a genomically-ordered relational database allowed us to provide a modular and robust platform for centralized storage and analysis of research and clinical data, currently totaling 8516 exomes and 112 genomes. The GLS integrates analytical systems, including machine learning algorithms for automated variant classification and prioritization, as well as phenotype extraction via natural language processing (NLP) of clinical notes. This GLS is extensible to additional analytic systems and growing research and clinical collections of genomic and other types of data.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genomics
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

